Interpace Diagnostics Enters Agreement with Predictive Oncology to Enhance Diagnosis of Thyroid Cancer Via AI-Driven Analysis Jul 18, 2019
Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business Supported by Investment from Ampersand Capital Partners Jul 15, 2019
Interpace Diagnostics Announces Coverage of Molecular Thyroid Testing by Independence Blue Cross Jun 20, 2019
Interpace Diagnostics Reports First Quarter 2019 Financial Results and Provides Business Update May 13, 2019
Interpace Diagnostics to Host Conference Call and Webcast to Discuss First Quarter 2019 Financial Results on Monday, May 13, 2019 May 6, 2019
